Cell Isolation Market Size, Share, Growth Analysis, By Product (Consumables, Instruments), By Cell Type (Human Cells, Animal Cells), By Cell Source, By Technique, By Application, By Region - Industry Forecast 2024-2031
Pluriselect Life Science Ug(Haftungsbeschrankt) & Co. KG(µ¶ÀÏ)
Invent Biotechnologies, Inc.(¹Ì±¹)
KSA
¿µ¹® ¸ñÂ÷
¿µ¹®¸ñÂ÷
Global Cell Isolation Market size was valued at USD 4.2 billion in 2022 and is poised to grow from USD 4.74 billion in 2023 to USD 12.42 billion by 2031, growing at a CAGR of 12.80% during the forecast period (2024-2031).
The global cell isolation market is witnessing robust growth driven by its critical role in applications such as biologics development, therapeutic protein synthesis, internal analysis, and research. Rising prevalence and costs of chronic diseases like cancer and COVID-19, coupled with government initiatives to bolster biotechnology, are key growth determinants. Companies like NanoString Technologies, Levitas Bio, and Bionano Genomics are enhancing their manufacturing processes and expanding product offerings, enabling precise cell selection for advanced applications. The COVID-19 pandemic further accelerated research in new treatment and diagnostic aids, with initiatives like the U.S. emergency spending bill of August 2020 boosting demand for cell isolation equipment. Growing reliance on biopharmaceuticals fuels the market as specialty and generic medicines expand exponentially.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cell Isolation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Cell Isolation Market Segmental Analysis
Global Cell Isolation Market is segmented by Product, Cell Type, Cell Source, Technique, Application, End User, and region. Based on Product, the market is segmented into Consumables, and Instruments. Based on Cell Type, the market is segmented into Human Cells, and Animal Cells. Based on Cell Source, the market is segmented into Adipose Tissue, Bone Marrow, Cord Blood/Embryonic Stem Cells, and Other Cell Sources. Based on Technique, the market is segmented into Centrifugation-Based Cell Isolation, Surface Marker-Based Cell Isolation, and Filtration-Based Cell Isolation. Based on Application, the market is segmented into Biomolecule Isolation, Cancer Research, Stem Cell Research, Tissue, Regeneration & Regenerative Medicine, In Vitro Diagnostics, and Other Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Hospitals & Diagnostic Laboratories, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Driver of the Global Cell Isolation Market
One of the key drivers of the global cell isolation market is the rising prevalence of chronic diseases, particularly cancer. As cancer cases surge globally, there is a growing demand for advanced research and treatment solutions. Cell isolation plays a pivotal role in cancer research by enabling the study of specific cell types, facilitating the development of targeted therapies and personalized medicine. Isolated cells provide critical insights into tumor biology, drug resistance, and immune responses, driving the creation of more effective treatments. Additionally, the increasing adoption of advanced therapies, such as immunotherapy, further boosts the demand for cell isolation techniques. This trend underscores the importance of innovation in the cell isolation market, as research institutes and biotech firms intensify their efforts to combat chronic diseases.
Restraints in the Global Cell Isolation Market
A significant restraint in the global cell isolation market is the high cost of specialized equipment and technologies required for isolating specific cell types. Advanced tools such as flow cytometers, centrifuges, and magnetic-activated cell sorting (MACS) systems are costly, limiting access, particularly for smaller research institutions and laboratories. Additionally, the ongoing expenses related to reagents, as well as the need for highly skilled personnel to operate the equipment, further elevate the financial burden. These factors may restrict the widespread adoption and utilization of advanced cell isolation techniques, particularly in regions with limited financial resources or budget constraints.
Market Trends of the Global Cell Isolation Market
A key trend shaping the global cell isolation market is the growing adoption of microfluidics technology. This innovative approach utilizes small quantities of fluids through microchannels to precisely separate cells based on characteristics such as length, shape, and other biological properties. Microfluidics is gaining significant traction for its ability to efficiently isolate rare cells, such as circulating tumor cells (CTCs) and stem cells, from complex biological samples. Its enhanced precision and performance, coupled with cost-effective processing that minimizes reagent usage, make it a highly attractive solution for both research and medical applications. As a result, microfluidics is poised to revolutionize cell isolation, offering improved accuracy and efficiency in diverse clinical and research settings.
Table of Contents
Introduction
Objectives of the Study
Definitions
Market Scope
Research Methodology
Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Porters Analysis
Competitive rivalry
Threat of Substitute Products
Bargaining Power of Buyers
Threat of New Entrants
Bargaining Power of Suppliers
Key Market Insights
Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Technology Analysis
Pricing Analysis
Value Chain Analysis
Patent Analysis
Supply Chain Analysis
Regulatory Landscape
Customer & Buying Criteria Analysis
Cell Isolation Market by Product
Market Overview
Consumables
Reagents, Kits, Media, And Sera
Beads
Magnetic Beads
Fluorescent Beads
Disposables
Instruments
Centrifuges
Cell Sorters
Magnetic-Activated Cell Separator Systems
Filtration Systems
Cell Isolation Market by Cell Type
Market Overview
Human Cells
Differentiated Cells
Stem Cells
Animal Cells
Cell Isolation Market by Cell Source
Market Overview
Adipose Tissue
Bone Marrow
Cord Blood/Embryonic Stem Cells
Other Cell Sources
Cell Isolation Market by Technique
Market Overview
Centrifugation-Based Cell Isolation
Surface Marker-Based Cell Isolation
Filtration-Based Cell Isolation
Cell Isolation Market by Application
Market Overview
Biomolecule Isolation
Cancer Research
Stem Cell Research
Tissue Regeneration & Regenerative Medicine
In Vitro Diagnostics
Other Applications
Cell Isolation Market by End User
Market Overview
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Hospitals & Diagnostic Laboratories
Other End Users
Cell Isolation Market Size by Region
Market Overview
North America
USA
Canada
Europe
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America
Brazil
Rest of Latin America
Middle East & Africa (MEA)
GCC Countries
South Africa
Rest of MEA
Competitive Landscape
Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023
Key Company Profiles
Danaher Corporation (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Merck KGAA (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Thermo Fisher Scientific Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
BD (Becton, Dickinson and Company) (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Sartorius AG (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Agilent Technologies, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Bio-Rad Laboratories, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Qiagen (Netherlands)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Revvity (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Lonza (Switzerland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Bio-Techne (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Terumo Corporation (Japan)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Miltenyi Biotec (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Takara Bio Inc. (Japan)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Genscript (China)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Standard Biotools (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Alfa Laval (Sweden)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Promega Corporation (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Cell Signaling Technology, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Micareo Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Applied Cells Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Stemcell Technologies (Canada)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Creative Bioarray (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Proteintech Group, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Magbio Genomics, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Akadeum Life Sciences (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
Pluriselect Life Science Ug (Haftungsbeschrankt) & Co. KG (Germany)